Primary Site >> Colorectal Cancer
Gene >> PRPF6
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: The effects of adverse growth conditions on the shedding of carcinoembryonic antigen from cultured LS180 colon cancer cells. PMID: 2372472 |
Ref: Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial. PMID: 11106123 |
Ref: Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial. PMID: 12187328 |
Ref: Raltitrexed-induced hepatotoxicity: multivariate analysis of predictive factors. PMID: 12960737 |
Ref: Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study. PMID: 21851185 |
Ref: TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. PMID: 22207630 Ref: Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents. PMID: 22285227 |
Ref: Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer. PMID: 23341073 |
Ref: An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth. PMID: 24788092 |
Ref: Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study. PMID: 26433487 |
Ref: Exploring Gender Differences in Self-Reported Physical Activity and Health Among Older Caregivers. PMID: 28632242 |